Cargando…
Coexistence of bla(IMP-4), bla(NDM-1) and bla(OXA-1) in bla(KPC-2)-producing Citrobacter freundii of clinical origin in China
PURPOSE: To explore the genetic characteristics of the IMP-4, NDM-1, OXA-1, and KPC-2 co-producing multidrug-resistant (MDR) clinical isolate, Citrobacter freundii wang9. METHODS: MALDI-TOF MS was used for species identification. PCR and Sanger sequencing analysis were used to identify resistance ge...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291173/ https://www.ncbi.nlm.nih.gov/pubmed/37378293 http://dx.doi.org/10.3389/fmicb.2023.1074612 |
_version_ | 1785062638531641344 |
---|---|
author | Qiao, Jie Chen, Yingying Ge, Haoyu Xu, Hao Guo, Xiaobing Liu, Ruishan Li, Chenyu Chen, Ruyan Gou, Jianjun Chen, Mantao Zheng, Beiwen |
author_facet | Qiao, Jie Chen, Yingying Ge, Haoyu Xu, Hao Guo, Xiaobing Liu, Ruishan Li, Chenyu Chen, Ruyan Gou, Jianjun Chen, Mantao Zheng, Beiwen |
author_sort | Qiao, Jie |
collection | PubMed |
description | PURPOSE: To explore the genetic characteristics of the IMP-4, NDM-1, OXA-1, and KPC-2 co-producing multidrug-resistant (MDR) clinical isolate, Citrobacter freundii wang9. METHODS: MALDI-TOF MS was used for species identification. PCR and Sanger sequencing analysis were used to identify resistance genes. In addition to agar dilution, broth microdilution was used for antimicrobial susceptibility testing (AST). We performed whole genome sequencing (WGS) of the strains and analyzed the resulting data for drug resistance genes and plasmids. Phylogenetic trees were constructed with maximum likelihood, plotted using MAGA X, and decorated by iTOL. RESULTS: Citrobacter freundii carrying bla(KPC-2), bla(IMP-4), bla(OXA-1), and bla(NDM-1) are resistant to most antibiotics, intermediate to tigecycline, and only sensitive to polymyxin B, amikacin, and fosfomycin. The bla(IMP-4) coexists with the bla(NDM-1) and the bla(OXA-1) on a novel transferable plasmid variant pwang9-1, located on the integron In1337, transposon TnAS3, and integron In2054, respectively. The gene cassette sequence of integron In1337 is IntI1-bla(IMP-4)-qacG2-aacA4′-catB3Δ, while the gene cassette sequence of In2054 is IntI1-aacA4cr-bla(OXA-1)-catB3-arr3-qacEΔ1-sul1. The bla(NDM-1) is located on the transposon TnAS3, and its sequence is IS91-sul-ISAba14-aph (3′)-VI-IS30-bla(NDM-1)-ble-trpF-dsbD-IS91. The bla(KPC-2) is located on the transposon Tn2 of plasmid pwang9-1, and its sequence is klcA-korC-ISkpn6-bla(KPC-2)-ISkpn27-tnpR-tnpA. Phylogenetic analysis showed that most of the 34\u00B0C. freundii isolates from China were divided into three clusters. Among them, wang1 and wang9 belong to the same cluster as two strains of C. freundii from environmental samples from Zhejiang. CONCLUSION: We found C. freundii carrying bla(IMP–4), bla(NDM–1), bla(OXA-1), and bla(KPC-2) for the first time, and conducted in-depth research on its drug resistance mechanism, molecular transfer mechanism and epidemiology. In particular, we found that bla(IMP-4), bla(OXA-1), and bla(NDM-1) coexisted on a new transferable hybrid plasmid that carried many drug resistance genes and insertion sequences. The plasmid may capture more resistance genes, raising our concern about the emergence of new resistance strains. |
format | Online Article Text |
id | pubmed-10291173 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102911732023-06-27 Coexistence of bla(IMP-4), bla(NDM-1) and bla(OXA-1) in bla(KPC-2)-producing Citrobacter freundii of clinical origin in China Qiao, Jie Chen, Yingying Ge, Haoyu Xu, Hao Guo, Xiaobing Liu, Ruishan Li, Chenyu Chen, Ruyan Gou, Jianjun Chen, Mantao Zheng, Beiwen Front Microbiol Microbiology PURPOSE: To explore the genetic characteristics of the IMP-4, NDM-1, OXA-1, and KPC-2 co-producing multidrug-resistant (MDR) clinical isolate, Citrobacter freundii wang9. METHODS: MALDI-TOF MS was used for species identification. PCR and Sanger sequencing analysis were used to identify resistance genes. In addition to agar dilution, broth microdilution was used for antimicrobial susceptibility testing (AST). We performed whole genome sequencing (WGS) of the strains and analyzed the resulting data for drug resistance genes and plasmids. Phylogenetic trees were constructed with maximum likelihood, plotted using MAGA X, and decorated by iTOL. RESULTS: Citrobacter freundii carrying bla(KPC-2), bla(IMP-4), bla(OXA-1), and bla(NDM-1) are resistant to most antibiotics, intermediate to tigecycline, and only sensitive to polymyxin B, amikacin, and fosfomycin. The bla(IMP-4) coexists with the bla(NDM-1) and the bla(OXA-1) on a novel transferable plasmid variant pwang9-1, located on the integron In1337, transposon TnAS3, and integron In2054, respectively. The gene cassette sequence of integron In1337 is IntI1-bla(IMP-4)-qacG2-aacA4′-catB3Δ, while the gene cassette sequence of In2054 is IntI1-aacA4cr-bla(OXA-1)-catB3-arr3-qacEΔ1-sul1. The bla(NDM-1) is located on the transposon TnAS3, and its sequence is IS91-sul-ISAba14-aph (3′)-VI-IS30-bla(NDM-1)-ble-trpF-dsbD-IS91. The bla(KPC-2) is located on the transposon Tn2 of plasmid pwang9-1, and its sequence is klcA-korC-ISkpn6-bla(KPC-2)-ISkpn27-tnpR-tnpA. Phylogenetic analysis showed that most of the 34\u00B0C. freundii isolates from China were divided into three clusters. Among them, wang1 and wang9 belong to the same cluster as two strains of C. freundii from environmental samples from Zhejiang. CONCLUSION: We found C. freundii carrying bla(IMP–4), bla(NDM–1), bla(OXA-1), and bla(KPC-2) for the first time, and conducted in-depth research on its drug resistance mechanism, molecular transfer mechanism and epidemiology. In particular, we found that bla(IMP-4), bla(OXA-1), and bla(NDM-1) coexisted on a new transferable hybrid plasmid that carried many drug resistance genes and insertion sequences. The plasmid may capture more resistance genes, raising our concern about the emergence of new resistance strains. Frontiers Media S.A. 2023-06-12 /pmc/articles/PMC10291173/ /pubmed/37378293 http://dx.doi.org/10.3389/fmicb.2023.1074612 Text en Copyright © 2023 Qiao, Chen, Ge, Xu, Guo, Liu, Li, Chen, Gou, Chen and Zheng. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Microbiology Qiao, Jie Chen, Yingying Ge, Haoyu Xu, Hao Guo, Xiaobing Liu, Ruishan Li, Chenyu Chen, Ruyan Gou, Jianjun Chen, Mantao Zheng, Beiwen Coexistence of bla(IMP-4), bla(NDM-1) and bla(OXA-1) in bla(KPC-2)-producing Citrobacter freundii of clinical origin in China |
title | Coexistence of bla(IMP-4), bla(NDM-1) and bla(OXA-1) in bla(KPC-2)-producing Citrobacter freundii of clinical origin in China |
title_full | Coexistence of bla(IMP-4), bla(NDM-1) and bla(OXA-1) in bla(KPC-2)-producing Citrobacter freundii of clinical origin in China |
title_fullStr | Coexistence of bla(IMP-4), bla(NDM-1) and bla(OXA-1) in bla(KPC-2)-producing Citrobacter freundii of clinical origin in China |
title_full_unstemmed | Coexistence of bla(IMP-4), bla(NDM-1) and bla(OXA-1) in bla(KPC-2)-producing Citrobacter freundii of clinical origin in China |
title_short | Coexistence of bla(IMP-4), bla(NDM-1) and bla(OXA-1) in bla(KPC-2)-producing Citrobacter freundii of clinical origin in China |
title_sort | coexistence of bla(imp-4), bla(ndm-1) and bla(oxa-1) in bla(kpc-2)-producing citrobacter freundii of clinical origin in china |
topic | Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291173/ https://www.ncbi.nlm.nih.gov/pubmed/37378293 http://dx.doi.org/10.3389/fmicb.2023.1074612 |
work_keys_str_mv | AT qiaojie coexistenceofblaimp4blandm1andblaoxa1inblakpc2producingcitrobacterfreundiiofclinicalorigininchina AT chenyingying coexistenceofblaimp4blandm1andblaoxa1inblakpc2producingcitrobacterfreundiiofclinicalorigininchina AT gehaoyu coexistenceofblaimp4blandm1andblaoxa1inblakpc2producingcitrobacterfreundiiofclinicalorigininchina AT xuhao coexistenceofblaimp4blandm1andblaoxa1inblakpc2producingcitrobacterfreundiiofclinicalorigininchina AT guoxiaobing coexistenceofblaimp4blandm1andblaoxa1inblakpc2producingcitrobacterfreundiiofclinicalorigininchina AT liuruishan coexistenceofblaimp4blandm1andblaoxa1inblakpc2producingcitrobacterfreundiiofclinicalorigininchina AT lichenyu coexistenceofblaimp4blandm1andblaoxa1inblakpc2producingcitrobacterfreundiiofclinicalorigininchina AT chenruyan coexistenceofblaimp4blandm1andblaoxa1inblakpc2producingcitrobacterfreundiiofclinicalorigininchina AT goujianjun coexistenceofblaimp4blandm1andblaoxa1inblakpc2producingcitrobacterfreundiiofclinicalorigininchina AT chenmantao coexistenceofblaimp4blandm1andblaoxa1inblakpc2producingcitrobacterfreundiiofclinicalorigininchina AT zhengbeiwen coexistenceofblaimp4blandm1andblaoxa1inblakpc2producingcitrobacterfreundiiofclinicalorigininchina |